These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 39141302)
1. On-Demand Vaccine Production via Dock-and-Display of Biotinylated Antigens on Bacterial Extracellular Vesicles. Weyant KB; Oloyede A; DeLisa MP Methods Mol Biol; 2024; 2843():195-216. PubMed ID: 39141302 [TBL] [Abstract][Full Text] [Related]
2. A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens. Weyant KB; Oloyede A; Pal S; Liao J; Jesus MR; Jaroentomeechai T; Moeller TD; Hoang-Phou S; Gilmore SF; Singh R; Pan DC; Putnam D; Locher C; de la Maza LM; Coleman MA; DeLisa MP Nat Commun; 2023 Jan; 14(1):464. PubMed ID: 36709333 [TBL] [Abstract][Full Text] [Related]
3. Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Irene C; Fantappiè L; Caproni E; Zerbini F; Anesi A; Tomasi M; Zanella I; Stupia S; Prete S; Valensin S; König E; Frattini L; Gagliardi A; Isaac SJ; Grandi A; Guella G; Grandi G Proc Natl Acad Sci U S A; 2019 Oct; 116(43):21780-21788. PubMed ID: 31591215 [TBL] [Abstract][Full Text] [Related]
4. Engineered Bacterial Outer Membrane Vesicles with Lipidated Heterologous Antigen as an Adjuvant-Free Vaccine Platform for Streptococcus suis. Li Q; Zhou G; Fei X; Tian Y; Wang S; Shi H Appl Environ Microbiol; 2023 Mar; 89(3):e0204722. PubMed ID: 36809058 [TBL] [Abstract][Full Text] [Related]
5. Proteome-minimized outer membrane vesicles from Zanella I; König E; Tomasi M; Gagliardi A; Frattini L; Fantappiè L; Irene C; Zerbini F; Caproni E; Isaac SJ; Grigolato M; Corbellari R; Valensin S; Ferlenghi I; Giusti F; Bini L; Ashhab Y; Grandi A; Grandi G J Extracell Vesicles; 2021 Feb; 10(4):e12066. PubMed ID: 33643549 [TBL] [Abstract][Full Text] [Related]
6. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles. Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064 [TBL] [Abstract][Full Text] [Related]
7. Outer membrane vesicles engineered to express membrane-bound antigen program dendritic cells for cross-presentation to CD8 Schetters STT; Jong WSP; Horrevorts SK; Kruijssen LJW; Engels S; Stolk D; Daleke-Schermerhorn MH; Garcia-Vallejo J; Houben D; Unger WWJ; den Haan JMM; Luirink J; van Kooyk Y Acta Biomater; 2019 Jun; 91():248-257. PubMed ID: 31003032 [TBL] [Abstract][Full Text] [Related]
8. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification. Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485 [TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles from genetically engineered Liu Q; Shang Y; Shen L; Yu X; Cao Y; Zeng L; Zhang H; Rao Z; Li Y; Tao Z; Liu Z; Huang X Virulence; 2024 Dec; 15(1):2367783. PubMed ID: 38937901 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of immunogenicity and protective efficacy of outer membrane vesicles from Salmonella Typhimurium and Salmonella Choleraesuis. Tian Y; Huang S; Zhou G; Fei X; Li YA; Li Q; Wang S; Shi H Vet Microbiol; 2024 Jul; 294():110131. PubMed ID: 38805917 [TBL] [Abstract][Full Text] [Related]
11. Isolation of Naturally Released Gonococcal Outer Membrane Vesicles as Vaccine Antigens. Francis IP; Lui X; Wetzler LM Methods Mol Biol; 2019; 1997():121-141. PubMed ID: 31119622 [TBL] [Abstract][Full Text] [Related]
12. Mechanistic insight into the TH1-biased immune response to recombinant subunit vaccines delivered by probiotic bacteria-derived outer membrane vesicles. Rosenthal JA; Huang CJ; Doody AM; Leung T; Mineta K; Feng DD; Wayne EC; Nishimura N; Leifer C; DeLisa MP; Mendez S; Putnam D PLoS One; 2014; 9(11):e112802. PubMed ID: 25426709 [TBL] [Abstract][Full Text] [Related]
13. Employing Escherichia coli-derived outer membrane vesicles as an antigen delivery platform elicits protective immunity against Acinetobacter baumannii infection. Huang W; Wang S; Yao Y; Xia Y; Yang X; Li K; Sun P; Liu C; Sun W; Bai H; Chu X; Li Y; Ma Y Sci Rep; 2016 Nov; 6():37242. PubMed ID: 27849050 [TBL] [Abstract][Full Text] [Related]
14. Bioengineered bacteria-derived outer membrane vesicles as a versatile antigen display platform for tumor vaccination via Plug-and-Display technology. Cheng K; Zhao R; Li Y; Qi Y; Wang Y; Zhang Y; Qin H; Qin Y; Chen L; Li C; Liang J; Li Y; Xu J; Han X; Anderson GJ; Shi J; Ren L; Zhao X; Nie G Nat Commun; 2021 Apr; 12(1):2041. PubMed ID: 33824314 [TBL] [Abstract][Full Text] [Related]
15. OMV Vaccines and the Role of TLR Agonists in Immune Response. Mancini F; Rossi O; Necchi F; Micoli F Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575921 [TBL] [Abstract][Full Text] [Related]
16. Outer membrane vesicles as a platform for the discovery of antibodies to bacterial pathogens. Lei EK; Azmat A; Henry KA; Hussack G Appl Microbiol Biotechnol; 2024 Feb; 108(1):232. PubMed ID: 38396192 [TBL] [Abstract][Full Text] [Related]
17. Molecular imaging of bacterial outer membrane vesicles based on bacterial surface display. Szöllősi D; Hajdrik P; Tordai H; Horváth I; Veres DS; Gillich B; Shailaja KD; Smeller L; Bergmann R; Bachmann M; Mihály J; Gaál A; Jezsó B; Barátki B; Kövesdi D; Bősze S; Szabó I; Felföldi T; Oszwald E; Padmanabhan P; Gulyás BZ; Hamdani N; Máthé D; Varga Z; Szigeti K Sci Rep; 2023 Oct; 13(1):18752. PubMed ID: 37907509 [TBL] [Abstract][Full Text] [Related]
18. Bacterial Outer Membrane Vesicles as a Versatile Tool in Vaccine Research and the Fight against Antimicrobial Resistance. Zhu Z; Antenucci F; Villumsen KR; Bojesen AM mBio; 2021 Aug; 12(4):e0170721. PubMed ID: 34372691 [TBL] [Abstract][Full Text] [Related]